KTKlaus Tatsch

Klaus Tatsch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Klaus Tatsch has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Update diagnostische Bildgebung des dopaminergen Systems

    by Klaus Tatsch

    Zusammenfassung: Die Arbeit gibt ein Update zu dem Einsatz der SPECT- und PET-Bildgebung des prä- und postsynaptischen dopaminergen Systems bei klinisch wichtigen Bewegungsstörungen. Die typischen Untersuchungsbefunde bei neurodegenerativen Parkinson-Syndromen (idiopathisch und nicht-idiopathisch), symptomatischen Parkinson-Syndromen und wichtigen Differentialdiagnosen werden beschrieben. Es wird auf den klinisch praktischen Stellenwert der Methoden eingegangen, deren diagnostische Aussagekraft und Limitationen bewertet, das Thema standardisierter Auswertungen angesprochen und auf die in Leitlinien festgehaltenen Einsatzbereiche Bezug genommen.

  • Seltene nuklearmedizinische Untersuchungen

    by Klaus Tatsch

    Die Themen des Heftes „Seltene nuklearmedizinische Untersuchungen“ mögen bei einigen Lesern das subjektive Empfinden hervorrufen hier Untersuchungsmethoden wiederzufinden, die in ihrem Berufsalltag keine oder fast keine Rolle (mehr) spielen. Andere wiederum sehen in dem Heft Verfahren beschrieben, die sie mehrmals wöchentlich durchführen und somit den Begriff „selten“ deshalb in Frage stellen. Die Gründe für beide Sichtweisen sind sicherlich vielschichtig und haben meist mit den Rahmenbedingungen der jeweiligen ärztlichen Tätigkeit zu tun (Klinik, Praxis, fachspezifische Schwerpunkte, Kooperationspartner, etc.). In dem Heft werden aus meiner Sicht Untersuchungsmethoden behandelt, die primär alle nicht „neu“ sind, aufgrund ihres speziellen Charakters jedoch Aussagen liefern, die nach wie vor nicht mit alternativen diagnostischen Verfahren in gleicher Weise oder besser zu erheben sind.

  • Ösophagusfunktionsszintigrafie

    by Klaus Tatsch

    Zusammenfassung: Die Ösophagusfunktionsszintigrafie ist ein einfach durchführbares, nicht invasives, quantifizierendes Verfahren zur Objektivierung einer Störung der Boluspassage durch die Speiseröhre. Die Methode dient primär der Diagnostik von Motilitätsstörungen des tubulären Ösophagusabschnitts. Die vorliegende Arbeit gibt eine Übersicht über die Durchführung, Auswertung und Interpretation szintigrafischer Untersuchungen des Bolustransits, wobei die Grundzüge der visuellen Interpretation von Passagebildern sowie die Möglichkeiten der quantitativen Auswertung dargelegt werden. An typischen Befundmustern werden die art- und differenzialdiagnostische Einordnung von Motilitätsstörungen erörtert.

  • Open Access

    Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update

    by Klaus Tatsch, Gabriele Poepperl

    This article gives an update on nigrostriatal dopamine terminal imaging, with emphasis on SPECT performed with the presynaptic dopamine transporter (DAT) ligand 123I-FP-CIT. The paper covers the rational use of this technique in the diagnostic work-up of patients with known or suspected parkinsonian syndromes. In detail, it addresses the impact of the method for the proof or exclusion of neurodegenerative parkinsonism, for its early and preclinical diagnosis, and for the evaluation of disease progression. The importance of normal DAT binding for differentiating symptomatic parkinsonism and relevant tremor syndromes from neurodegeneration is highlighted. Particularly emphasized is the role of DAT SPECT for diagnosing Lewy body dementia and its separation from Alzheimer dementia. Finally, some remarks deal with the economic aspects of the use of these imaging techniques in the clinical setting.


  • Open Access

    No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT

    by Gerda Thomsen, Gitte M Knudsen, Peter S Jensen, Morten Ziebell, Klaus K Holst, Susanne Asenbaum, Jan Booij, Jacques Darcourt, John C Dickson, Özlem L Kapucu, et al.

    Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D2-like receptors. Molecular imaging studies of the relationship between DAT availability/dopamine synthesis capacity and active cigarette smoking have shown conflicting results. Through the collaboration between 13 SPECT centres located in 10 different European countries, a database of FP-CIT-binding in healthy controls was established. We used the database to test the hypothesis that striatal DAT availability is changed in active smokers compared to non-smokers and ex-smokers.


  • Diagnostik des Parkinson-Syndroms mit [123I]FP-CIT und SPECT

    by K. Tatsch

    Die Arbeit gibt einen Überblick über den Einsatz der SPECT-Bildgebung des präsynaptischen Dopamintransporters mit [123I]FP-CIT bei der Abklärung von Parkinson-Syndromen. Abgehandelt wird der Stellenwert dieser Methodik beim Nachweis neurodegenerativer Parkinson-Syndrome, für deren Früh- und präklinische Diagnostik sowie für die Beurteilung der Krankheitsprogression. In der Abgrenzung der symptomatischen PS und wichtiger Tremorsyndrome von den neurodegenerativen PS wird die Bedeutung normaler FP-CIT-SPECT-Befunde eingehend erläutert. Schließlich wird der Stellenwert der Methode bei der Diagnostik der Lewy-Body-Demenz und deren Abgrenzung von der Alzheimer-Demenz beleuchtet. Kurze Betrachtungen zur ökonomischen Seite von [123I]FP-CIT-Untersuchungen runden die Ausführungen ab. This paper gives an overview on the use of presynaptic dopamine transporter imaging with [123I]FP-CIT and SPECT in the diagnostic work-up of parkinsonism. The role of this method for diagnosing the various forms of neurodegenerative parkinsonism, for their early and preclinical diagnosis, and for assessment of disease progression is highlighted. The clinical impact of normal results of DAT-binding in the assessment of symptomatic parkinsonism including relevant tremor syndromes in contrast to the pathologic imaging results in neurodegenerative parkinsonism is critically addressed. Further, the role of [123I]FP-CIT imaging in establishing the diagnosis of dementia with Lewy bodies and its powerful differentiation from Alzheimer dementia is noted. Finally some concluding remarks follow on economic aspects of the application of [123I]FP-CIT SPECT in the respective indications.

    • 1 February 2012
      • Vol. 56  (1) , 27-38

    Quantitative approaches to dopaminergic brain imaging.

    by K Tatsch, G Poepperl

    During the last three decades dopaminergic brain imaging has emerged from a dedicated research tool to a widespread and routinely used application. The rationale behind this development is on the one hand the well known pathologic involvement of the dopaminergic pathway in various neuro-psychiatric diseases, and on the other hand the increasing availability of specific radioligands for picking up pre- and postsynaptic dopaminergic key functions. In particular the commercial availability of SPECT tracers but also the growing number of positron emission tomography/computed tomography (PET/CT) imaging devices has contributed to the steadily increasing number of diagnostic applications. In an era aiming for accurate diagnosis in the early and even preclinical stage of disease, refined methodologies are required to detect even subtle changes. In this context quantification of dopaminergic functions more and more gains importance. Whereas earlier visual assessment was considered sufficient to characterize findings, today refined quantitative tools have the potential to deliver information beyond. This review briefly addresses the development of quantitative methods for dopaminergic brain imaging, from simple manual ratio based applications to various automated methodologies, some of them including tools for correction of physical parameters such as scatter and septal penetration and partial volume effects. Voxel based analysis methods will be covered and also kinetic analyses will be briefly touched. The main focus is directed at SPECT rather than PET methodologies due to the clinical impact of the first. Finally, some thoughts regarding the impact of standardization and harmonization of protocols for imaging and processing will be discussed, including the use of normal data bases for reference.


  • Open Access

    Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

    by Yvonne Nadine Fahmueller, Dorothea Nagel, Ralf-Thorsten Hoffmann, Klaus Tatsch, Tobias Jakobs, Petra Stieber, Stefan Holdenrieder

    Background: Selective Internal Radiation Therapy (SIRT) is a new and effective locoregional anticancer therapy for colorectal cancer patients with liver metastases. Markers for prediction of therapy response and prognosis are needed for the individual management of those patients undergoing SIRT. Methods: Blood samples were prospectively and consecutively taken from 49 colorectal cancer patients with extensive hepatic metastases before, three, six, 24 and 48 h after SIRT to analyze the concentrations of nucleosomes and further laboratory parameters, and to compare them with the response to therapy regularly determined 3 months after therapy and with overall survival. Results: Circulating nucleosomes, cytokeratin-19 fragments (CYFRA 21-1), carcinoembryonic antigen (CEA), C-reactive protein (CRP) and various liver markers increased already 24 h after SIRT. Pretherapeutical levels of CYFRA 21-1, CEA, cancer antigen 19-9 (CA 19-9), asparate-aminotransferase (AST) and lactate dehydrogenase (LDH) as well as 24 h values of nucleosomes were significantly higher in patients suffering from disease progression (N = 35) than in non-progressive patients (N = 14). Concerning overall survival, CEA, CA 19-9, CYFRA 21-1, CRP, LDH, AST, choline esterase (CHE), gamma-glutamyl-transferase, alkaline phosphatase, and amylase (all 0 h, 24 h) and nucleosomes (24 h) were found to be prognostic relevant markers in univariate analyses. In multivariate Cox-Regression analysis, the best prognostic model was obtained for the combination of CRP and AST. When 24 h values were additionally included, nucleosomes (24 h) further improved the existing model. Conclusion: Panels of biochemical markers are helpful to stratify pretherapeutically colorectal cancer patients for SIR-therapy and to early estimate the response to SIR-therapy.